Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROVER Japan/ Real-world Outcomes of Patients Treated With Vericiguat in Japanese Routine Care: a Retrospective Cohort Study Using a Hospital Administrative Database

NCT06697353 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06697353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06697353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROVER Japan/ Real-world Outcomes of Patients Treated With Vericiguat in Japanese Routine Care: a Retrospective Cohort Study Using a Hospital Administrative Database
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 1, 2024
Completion date
September 19, 2025
Enrollment
4,936 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, chronic heart failure with reduced ejection fraction